These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32500746)

  • 1. Modern approaches for the phenotyping of cytochrome P450 enzymes in children.
    Magliocco G; Daali Y
    Expert Rev Clin Pharmacol; 2020 Jul; 13(7):671-674. PubMed ID: 32500746
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.
    Streetman DS; Bertino JS; Nafziger AN
    Pharmacogenetics; 2000 Apr; 10(3):187-216. PubMed ID: 10803676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isoenzymes of the cytochrome P450 system: an accident or a physiologically significant concept?].
    Klotz U
    Pharm Unserer Zeit; 1996 Jul; 25(4):193-5. PubMed ID: 8927633
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.
    Magliocco G; Thomas A; Desmeules J; Daali Y
    Clin Pharmacokinet; 2019 Nov; 58(11):1373-1391. PubMed ID: 31131437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human hepatic cytochromes P450 involved in drug metabolism.
    Wrighton SA; Stevens JC
    Crit Rev Toxicol; 1992; 22(1):1-21. PubMed ID: 1616599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Storage stability study of porcine hepatic and intestinal cytochrome P450 isoenzymes by use of a newly developed and fully validated highly sensitive HPLC-MS/MS method.
    Schelstraete W; Devreese M; Croubels S
    Anal Bioanal Chem; 2018 Feb; 410(6):1833-1843. PubMed ID: 29327113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CombiCap: A novel drug formulation for the basel phenotyping cocktail.
    Camblin M; Berger B; Haschke M; Krähenbühl S; Huwyler J; Puchkov M
    Int J Pharm; 2016 Oct; 512(1):253-261. PubMed ID: 27566010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
    Carosati E
    Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotyping of drug metabolism in infants and children: potentials and problems.
    Rane A
    Pediatrics; 1999 Sep; 104(3 Pt 2):640-3. PubMed ID: 10469807
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
    Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction phenotyping: current industry efforts to identify enzymes responsible for metabolizing drug candidates.
    Harper TW; Brassil PJ
    AAPS J; 2008; 10(1):200-7. PubMed ID: 18446520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes and the response to drugs.
    Caraco Y
    N Engl J Med; 2004 Dec; 351(27):2867-9. PubMed ID: 15625340
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly.
    Wauthier V; Verbeeck RK; Calderon PB
    Curr Med Chem; 2007; 14(7):745-57. PubMed ID: 17346160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human P450s in the metabolism of drugs: molecular modelling of enzyme-substrate interactions.
    Lewis DF
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):5-8. PubMed ID: 16922648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cytochrome p450 activity decreases in children with high pediatric end-stage liver disease scores.
    De Bock L; Boussery K; Van Winckel M; De Paepe P; Rogiers X; Stephenne X; Sokal E; Van Bocxlaer J
    Drug Metab Dispos; 2013 Feb; 41(2):390-7. PubMed ID: 23150427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the pharmacogenetics of cytochrome P450 enzymes may affect prescribing.
    Roberts RL; Begg EJ; Joyce PR; Kennedy MA
    N Z Med J; 2002 Mar; 115(1150):137-40. PubMed ID: 12013308
    [No Abstract]   [Full Text] [Related]  

  • 20. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.